Velsera

Gold Sponsor

Velsera’s mission is to be the discovery, evidence generation, and clinical delivery platform for precision medicine. We help experts in clinical diagnostics and life sciences make better decisions about providing the right therapy to the right patients at the right time.
Velsera was founded in 2023 as a result of the merger of Seven Bridges, PierianDx and UgenTec.
For more information, visit www.velsera.com.